Evidence map›Paper›PMID 23650397›Full record

Trial reportProceedings of the National Academy of Sciences of the United States of America2013

Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis.

Christoph Anacker, Annamaria Cattaneo, Ksenia Musaelyan, Patricia A Zunszain, Mark Horowitz, Raffaella Molteni, Alessia Luoni, Francesca Calabrese, Katherine Tansey, Massimo Gennarelli and 5 more

Open access · greenAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 188 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
188citing papers in PubMed, 4 pooled it
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

188 citing papers in PubMed, 4 syntheses or guidelines pooled it, 319 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

128 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Christoph AnackerStress, Psychiatry and Immunology Laboratory, Department of Psychological Medicine, Institute of Psychiatry, King's College London, London SE5 9NU, United Kingdom. Christoph.Anacker@kcl.ac.uk
Annamaria Cattaneo
Ksenia Musaelyan
Patricia A Zunszain
Mark Horowitz
Raffaella Molteni
Alessia Luoni
Francesca Calabrese
Katherine Tansey
Massimo Gennarelli
Sandrine Thuret
Jack Price
Rudolf Uher
Marco A Riva
Carmine M Pariante
King's College London · GBUniversity of Milan · ITMedical Research Council · GBCentro San Giovanni di Dio Fatebenefratelli · ITNational Institute for Health Research · GB

Funding

Medical Research Council G108/603Medical Research Council MR/J002739/1
6 · The paper itself

Abstract

Stress and glucocorticoid hormones regulate hippocampal neurogenesis, but the molecular mechanisms mediating these effects are poorly understood. Here we identify the glucocorticoid receptor (GR) target gene, serum- and glucocorticoid-inducible kinase 1 (SGK1), as one such mechanism. Using a human hippocampal progenitor cell line, we found that a small molecule inhibitor for SGK1, GSK650394, counteracted the cortisol-induced reduction in neurogenesis. Moreover, gene expression and pathway analysis showed that inhibition of the neurogenic Hedgehog pathway by cortisol was SGK1-dependent. SGK1 also potentiated and maintained GR activation in the presence of cortisol, and even after cortisol withdrawal, by increasing GR phosphorylation and GR nuclear translocation. Experiments combining the inhibitor for SGK1, GSK650394, with the GR antagonist, RU486, demonstrated that SGK1 was involved in the cortisol-induced reduction in progenitor proliferation both downstream of GR, by regulating relevant target genes, and upstream of GR, by increasing GR function. Corroborating the relevance of these findings in clinical and rodent settings, we also observed a significant increase of SGK1 mRNA in peripheral blood of drug-free depressed patients, as well as in the hippocampus of rats subjected to either unpredictable chronic mild stress or prenatal stress. Our findings identify SGK1 as a mediator for the effects of cortisol on neurogenesis and GR function, with particular relevance to stress and depression.

Indexed as

NeurogenesisStress, PhysiologicalActive Transport, Cell NucleusAdultAnimalsBenzoatesBridged Bicyclo Compounds, HeterocyclicCell Line, TransformedCell NucleusDepressionFemaleGlucocorticoidsHedgehog ProteinsHippocampusHumansHydrocortisone2-cyclopentyl-4-(5-phenyl-1H-pyrrolo(2,3-b)pyridin-3-yl)-benzoic acidBenzoatesBridged Bicyclo Compounds, HeterocyclicGlucocorticoidsHedgehog ProteinsHydrocortisoneImmediate-Early ProteinsMifepristoneNerve Tissue ProteinsProtein Serine-Threonine KinasesReceptors, GlucocorticoidRNA, MessengerSerum-Glucocorticoid Regulated Kinasesantidepressantshypothalamus–pituitary–adrenal axisneuroplasticitystem cells

Identifiers

PMID23650397
PMCPMC3666742
OpenAlexW2038487059

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.